We are live on ! Find out more
RKDA icon

Arcadia Biosciences
RKDA

15 hedge funds and large institutions have $1.97M invested in Arcadia Biosciences in 2020 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 4

61% more capital invested

Capital invested by funds: $1.22M → $1.97M (+$748K)

25% more funds holding

Funds holding: 12 → 15 (+3)

0.03% more ownership

Funds ownership: 0.12% → 0.15% (+0.03%)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

Holders
15
Holders Change
+3
Holders Change %
+25%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
2
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$232K
2
BlackRock
BlackRock
New York
+$86.6K
3
LPL Financial
LPL Financial
California
+$60.2K
4
HighTower Advisors
HighTower Advisors
Illinois
+$51.5K
5
CA
Calton & Associates
Florida
+$50.5K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$126K
2
Citadel Advisors
Citadel Advisors
Florida
-$33K
3
Morgan Stanley
Morgan Stanley
New York
-$6.53K
4
Victory Capital Management
Victory Capital Management
Texas
-$6K
5
Northern Trust
Northern Trust
Illinois
-$1.87K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$964K – – –
SM
2
Sabby Management
Florida
$224K +$232K +1,490 New
Geode Capital Management
3
Geode Capital Management
Massachusetts
$184K – – –
VF
4
Virtu Financial
New York
$113K +$116K +749 New
BlackRock
5
BlackRock
New York
$85K +$86.6K +557 +11,140%
Northern Trust
6
Northern Trust
Illinois
$69K -$1.87K -12 -3%
Wells Fargo
7
Wells Fargo
California
$63K +$1.55K +10 +2%
LPL Financial
8
LPL Financial
California
$58K +$60.2K +387 New
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$56K – – –
HighTower Advisors
10
HighTower Advisors
Illinois
$50K +$51.5K +331 New
CA
11
Calton & Associates
Florida
$49K +$50.5K +325 New
Morgan Stanley
12
Morgan Stanley
New York
$46K -$6.53K -42 -12%
CA
13
Clearstead Advisors
Ohio
$4K – – –
UBS Group
14
UBS Group
Switzerland
$4K +$3.58K +23 New
Renaissance Technologies
15
Renaissance Technologies
New York
– -$126K -1,102 Closed
Citadel Advisors
16
Citadel Advisors
Florida
– -$33K -286 Closed
Victory Capital Management
17
Victory Capital Management
Texas
– -$6K -61 Closed
Bank of America
18
Bank of America
North Carolina
– +$156 +1 New

RKDA Hedge Fund Activity: Q2 2020 in Review

15 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q2 2020, worth a combined $1.97M — up 61% from $1.22M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new RKDA positions and 4 closed out — a net gain of 3 holders — while 2 added to existing stakes and 2 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $232K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $126K sold.

  • 15 institutional investors held Arcadia Biosciences (RKDA) as of Q2 2020, up from 12 in Q1 2020.
  • Funds reported $1.97M of Arcadia Biosciences stock for Q2 2020, up 61% quarter-over-quarter.
  • 7 funds opened new Arcadia Biosciences positions in Q2 2020 and 4 closed out, a net change of +3 holders.
  • The largest Arcadia Biosciences buyer in Q2 2020 was Sabby Management, an estimated $232K added.
  • The largest Arcadia Biosciences seller in Q2 2020 was Renaissance Technologies, an estimated $126K sold.

Based on aggregated 13F filings for Q2 2020.